• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

寻找抗寄生虫药物的当前方向。

The Current Directions of Searching for Antiparasitic Drugs.

机构信息

Department of Organic Chemistry, Faculty of Pharmacy, Medical University of Lublin, 4A Chodzki Street, 20-093 Lublin, Poland.

出版信息

Molecules. 2022 Feb 24;27(5):1534. doi: 10.3390/molecules27051534.

DOI:10.3390/molecules27051534
PMID:35268635
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8912034/
Abstract

Parasitic diseases are still a huge problem for mankind. They are becoming the main cause of chronic diseases in the world. Migration of the population, pollution of the natural environment, and climate changes cause the rapid spread of diseases. Additionally, a growing resistance of parasites to drugs is observed. Many research groups are looking for effective antiparasitic drugs with low side effects. In this work, we present the current trends in the search for antiparasitic drugs. We report known drugs used in other disease entities with proven antiparasitic activity and research on new chemical structures that may be potential drugs in parasitic diseases. The described investigations of antiparasitic compounds can be helpful for further drug development.

摘要

寄生虫病仍然是人类的一个巨大问题。它们正成为世界范围内慢性病的主要病因。人口迁移、自然环境的污染以及气候变化导致疾病迅速传播。此外,寄生虫对药物的耐药性也在不断增加。许多研究小组正在寻找具有低副作用的有效抗寄生虫药物。在这项工作中,我们展示了寻找抗寄生虫药物的当前趋势。我们报告了已知在其他疾病实体中使用的具有已证实抗寄生虫活性的药物,以及对可能成为寄生虫病潜在药物的新化学结构的研究。所描述的抗寄生虫化合物的研究可能有助于进一步的药物开发。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82f3/8912034/31a3436a6246/molecules-27-01534-g020.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82f3/8912034/87579312bb03/molecules-27-01534-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82f3/8912034/ddb85965aee1/molecules-27-01534-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82f3/8912034/c25da9d57a57/molecules-27-01534-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82f3/8912034/7fcb51572c34/molecules-27-01534-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82f3/8912034/736bece7f698/molecules-27-01534-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82f3/8912034/05c535ae1454/molecules-27-01534-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82f3/8912034/066c6a7cf887/molecules-27-01534-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82f3/8912034/6efb5811628e/molecules-27-01534-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82f3/8912034/8ffe7104d389/molecules-27-01534-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82f3/8912034/f8b9d3677246/molecules-27-01534-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82f3/8912034/2e1e9ed47503/molecules-27-01534-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82f3/8912034/01c77cadf270/molecules-27-01534-g012a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82f3/8912034/cadcaa7be7bd/molecules-27-01534-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82f3/8912034/ad91ac1436e5/molecules-27-01534-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82f3/8912034/302578c38059/molecules-27-01534-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82f3/8912034/7707d3293f60/molecules-27-01534-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82f3/8912034/8b880f3fcb2c/molecules-27-01534-g017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82f3/8912034/87cc7b19f2a0/molecules-27-01534-g018.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82f3/8912034/12c085c13b56/molecules-27-01534-g019.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82f3/8912034/31a3436a6246/molecules-27-01534-g020.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82f3/8912034/87579312bb03/molecules-27-01534-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82f3/8912034/ddb85965aee1/molecules-27-01534-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82f3/8912034/c25da9d57a57/molecules-27-01534-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82f3/8912034/7fcb51572c34/molecules-27-01534-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82f3/8912034/736bece7f698/molecules-27-01534-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82f3/8912034/05c535ae1454/molecules-27-01534-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82f3/8912034/066c6a7cf887/molecules-27-01534-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82f3/8912034/6efb5811628e/molecules-27-01534-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82f3/8912034/8ffe7104d389/molecules-27-01534-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82f3/8912034/f8b9d3677246/molecules-27-01534-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82f3/8912034/2e1e9ed47503/molecules-27-01534-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82f3/8912034/01c77cadf270/molecules-27-01534-g012a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82f3/8912034/cadcaa7be7bd/molecules-27-01534-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82f3/8912034/ad91ac1436e5/molecules-27-01534-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82f3/8912034/302578c38059/molecules-27-01534-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82f3/8912034/7707d3293f60/molecules-27-01534-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82f3/8912034/8b880f3fcb2c/molecules-27-01534-g017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82f3/8912034/87cc7b19f2a0/molecules-27-01534-g018.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82f3/8912034/12c085c13b56/molecules-27-01534-g019.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82f3/8912034/31a3436a6246/molecules-27-01534-g020.jpg

相似文献

1
The Current Directions of Searching for Antiparasitic Drugs.寻找抗寄生虫药物的当前方向。
Molecules. 2022 Feb 24;27(5):1534. doi: 10.3390/molecules27051534.
2
[Antiparasitic drugs. Review of the useful drugs in the treatment of classic and emergent parasitic diseases].[抗寄生虫药物。经典和新发寄生虫病治疗中常用药物的综述]
Rev Esp Quimioter. 2009 Jun;22(2):93-105.
3
2-Amino-1,3,4-thiadiazoles as prospective agents in trypanosomiasis and other parasitoses.2-氨基-1,3,4-噻二唑类化合物作为抗锥虫病和其他寄生虫病的潜在药物。
Acta Pharm. 2020 Sep 1;70(3):259-290. doi: 10.2478/acph-2020-0031.
4
APDDD: Animal parasitic diseases and drugs database.APDDD:动物寄生虫病与药物数据库。
Comp Immunol Microbiol Infect Dis. 2024 Jan;104:102096. doi: 10.1016/j.cimid.2023.102096. Epub 2023 Nov 15.
5
Therapeutic Potential of Marine-Derived Cyclic Peptides as Antiparasitic Agents.海洋源环肽作为抗寄生虫药物的治疗潜力。
Mar Drugs. 2023 Nov 25;21(12):609. doi: 10.3390/md21120609.
6
Aromatic diamidines as antiparasitic agents.作为抗寄生虫剂的芳香二脒类化合物。
Expert Opin Investig Drugs. 2005 Aug;14(8):957-72. doi: 10.1517/13543784.14.8.957.
7
Resistance of internal and external parasites to antiparasitic drugs.体内外寄生虫对抗寄生虫药物的耐药性。
Ann Parasitol Hum Comp. 1991;66 Suppl 1:69-70. doi: 10.1051/parasite/199166269.
8
Predicting drugs and proteins in parasite infections with topological indices of complex networks: theoretical backgrounds, applications, and legal issues.用复杂网络拓扑指数预测寄生虫感染中的药物和蛋白质:理论背景、应用和法律问题。
Curr Pharm Des. 2010;16(24):2737-64. doi: 10.2174/138161210792389234.
9
Current antiparasitic drug targets and a paradigm shift in discovery of new antiparasitic drugs and vaccines.当前的抗寄生虫药物靶点以及新型抗寄生虫药物和疫苗发现中的范式转变。
Curr Drug Targets. 2008 Nov;9(11):921. doi: 10.2174/138945008786786145.
10
Parasitic infections and myositis.寄生虫感染和肌炎。
Parasitol Res. 2012 Jan;110(1):1-18. doi: 10.1007/s00436-011-2609-8. Epub 2011 Sep 1.

引用本文的文献

1
Molecularly Imprinted Electrochemical Sensors for Halogenated anti-Infective Agent Detection: A Review of Current Developments and Prospects.用于卤化抗感染剂检测的分子印迹电化学传感器:当前进展与前景综述
ACS Omega. 2025 Aug 7;10(32):35327-35351. doi: 10.1021/acsomega.5c03269. eCollection 2025 Aug 19.
2
Biomedical potential of agricultural waste extracts: phytochemicals with antioxidant, anti-inflammatory, anticancer, and anti-parasitic activities.农业废弃物提取物的生物医学潜力:具有抗氧化、抗炎、抗癌和抗寄生虫活性的植物化学物质。
3 Biotech. 2025 Jul;15(7):231. doi: 10.1007/s13205-025-04407-1. Epub 2025 Jul 1.
3

本文引用的文献

1
4-Arylthiosemicarbazide derivatives as a new class of tyrosinase inhibitors and anti- agents.4-芳基硫代缩氨基脲衍生物作为一类新型的酪氨酸酶抑制剂和抗剂。
J Enzyme Inhib Med Chem. 2021 Dec;36(1):1145-1164. doi: 10.1080/14756366.2021.1931164.
2
1,3,4-Thiadiazoles Effectively Inhibit Proliferation of .1,3,4-噻二唑类化合物有效抑制.的增殖。
Cells. 2021 Apr 29;10(5):1053. doi: 10.3390/cells10051053.
3
Promising hit compounds against resistant trichomoniasis: Synthesis and antiparasitic activity of 3-(ω-aminoalkoxy)-1-benzyl-5-nitroindazoles.
Aqueous Extracts of Carica papaya Embryogenic Callus Kill Entamoeba histolytica Trophozoites and Orally Protect against the Development of Amoebic Liver Abscesses in Hamsters.
番木瓜胚性愈伤组织水提取物可杀死溶组织内阿米巴滋养体,并对仓鼠阿米巴肝脓肿的发生起到口服保护作用。
Acta Parasitol. 2025 Jun 11;70(3):134. doi: 10.1007/s11686-025-01071-6.
4
Repurposing of Amiodarone for treatment of muscle phase of experimental trichinellosis spiralis.将胺碘酮重新用于治疗实验性旋毛虫病的肌肉期。
J Parasit Dis. 2025 Jun;49(2):419-425. doi: 10.1007/s12639-024-01763-2. Epub 2024 Dec 6.
5
The Paradigm Shift of Using Natural Molecules Extracted from Northern Canada to Combat Malaria.利用从加拿大北部提取的天然分子抗击疟疾的范式转变。
Infect Dis Rep. 2024 Jun 26;16(4):543-560. doi: 10.3390/idr16040041.
6
Therapeutic efficacy of candidate antischistosomal drugs in a murine model of schistosomiasis mansoni.候选抗血吸虫药物在曼氏血吸虫病小鼠模型中的治疗效果。
Parasitol Res. 2024 May 21;123(5):215. doi: 10.1007/s00436-024-08236-8.
7
Overview of Research on Leishmaniasis in Africa: Current Status, Diagnosis, Therapeutics, and Recent Advances Using By-Products of the Sargassaceae Family.非洲利什曼病研究综述:现状、诊断、治疗以及利用马尾藻科副产物的最新进展
Pharmaceuticals (Basel). 2024 Apr 18;17(4):523. doi: 10.3390/ph17040523.
8
Therapeutic applications of carbohydrate-based compounds: a sweet solution for medical advancement.基于碳水化合物的化合物的治疗应用:医学进步的甜蜜解决方案。
Mol Divers. 2024 Dec;28(6):4553-4579. doi: 10.1007/s11030-024-10810-2. Epub 2024 Mar 30.
9
Synthesis and Evaluation of Marine-Inspired Compounds Result in Hybrids with Antitrypanosomal and Antileishmanial Activities.海洋源灵感化合物的合成与评价导致具有抗锥虫和抗利什曼原虫活性的杂种。
Mar Drugs. 2023 Oct 24;21(11):551. doi: 10.3390/md21110551.
10
Synthesis and anthelmintic activity of novel thiosemicarbazide and 1,2,4-triazole derivatives: In vitro, in vivo, and in silico study.新型硫代卡巴肼和 1,2,4-三唑衍生物的合成及驱虫活性:体外、体内和计算机研究。
J Adv Res. 2024 Jun;60:57-73. doi: 10.1016/j.jare.2023.07.004. Epub 2023 Jul 17.
有前途的抗滴虫感染化合物:3-(ω-氨基烷氧基)-1-苄基-5-硝基吲唑的合成及抗寄生虫活性。
Bioorg Med Chem Lett. 2021 Apr 1;37:127843. doi: 10.1016/j.bmcl.2021.127843. Epub 2021 Feb 5.
4
High concentrations of membrane-fed ivermectin are required for substantial lethal and sublethal impacts on Aedes aegypti.高浓度的膜喂伊维菌素对埃及伊蚊具有显著的致死和亚致死影响。
Parasit Vectors. 2021 Jan 6;14(1):9. doi: 10.1186/s13071-020-04512-5.
5
Collateral Impact of Community-Directed Treatment with Ivermectin (CDTI) for Onchocerciasis on Parasitological Indicators of Infection.伊维菌素社区定向治疗(CDTI)对盘尾丝虫病的附带影响:关于感染的寄生虫学指标
Pathogens. 2020 Dec 12;9(12):1043. doi: 10.3390/pathogens9121043.
6
Population pharmacokinetics of ivermectin for the treatment of scabies in Indigenous Australian children.伊维菌素治疗澳大利亚原住民儿童疥疮的群体药代动力学。
PLoS Negl Trop Dis. 2020 Dec 7;14(12):e0008886. doi: 10.1371/journal.pntd.0008886. eCollection 2020 Dec.
7
New Pyrano-4H-benzo[g]chromene-5,10-diones with Antiparasitic and Antioxidant Activities.具有抗寄生虫和抗氧化活性的新型吡喃并[4H]-苯并[g]色烯-5,10-二酮。
Chem Biodivers. 2021 Jan;18(1):e2000839. doi: 10.1002/cbdv.202000839. Epub 2020 Dec 17.
8
Antischistosomal properties of aurone derivatives against juvenile and adult worms of Schistosoma mansoni.白杨素衍生物抗曼氏血吸虫幼、成虫的抗血吸虫作用。
Acta Trop. 2021 Jan;213:105741. doi: 10.1016/j.actatropica.2020.105741. Epub 2020 Nov 5.
9
Antiparasitic Behavior of Trifluoromethylated Pyrazole 2-Amino-1,3,4-thiadiazole Hybrids and Their Analogues: Synthesis and Structure-Activity Relationship.三氟甲基化吡唑-2-氨基-1,3,4-噻二唑杂化物及其类似物的抗寄生虫行为:合成与构效关系
Front Pharmacol. 2020 Oct 7;11:591570. doi: 10.3389/fphar.2020.591570. eCollection 2020.
10
Novel Linezolid analogues with antiparasitic activity against Hymenolepis nana.具有抗曼氏迭宫绦虫活性的新型利奈唑胺类似物。
Bioorg Chem. 2020 Dec;105:104359. doi: 10.1016/j.bioorg.2020.104359. Epub 2020 Oct 7.